Simvastatin reverses podocyte injury but not mesangial expansion in early stage type 2 diabetes mellitus

P. Wei, P. R. Grimm, D. C. Settles, C. R. Balwanz, B. J. Padanilam, S. C. Sansom

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Simvastatin reverses podocyte injury but not mesangial expansion in early stage type 2 diabetes mellitus'. Together they form a unique fingerprint.

Medicine & Life Sciences